Clinical Trials Browser

Burkitt Lymphoma × Injections × 90 days × Clear all

NCT06580301 2026-02-06

Study of YK012 in B-cell Acute Lymphoblastic Leukemia

Phase 1/2 Recruiting

Burkitt Lymphoma